Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services

About

Company description

Ajinomoto will have two businesses represented at CPhI: the Amino Science division and Ajinomoto Bio-Pharma Services. Ajinomoto Amino Sciences develops and manufactures high quality amino acids for the bio-pharmaceutical industry. The amino acids are produced under cGMP conditions with non-animal materials, and are unsurpassed in quality and purity. Ajinomoto Bio-Pharma Services is comprised of the recently unified Ajinomoto Althea and OmniChem organizations. Ajinomoto Bio-Pharma Services is a global and fully integrated CDMO for small and large molecules, providing comprehensive process development services, cGMP manufacturing and aseptic fill finish services, including ADCs/cytotoxics and oligonuceotides.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Advanced Intermediates |Amino Acids More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 10F110 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 111H40 See our Exhibitor Profile   See full Exhibitor List

News about Ajinomoto Bio-Pharma Services

Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry

10 Oct 2018

Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry

Ajinomoto Althea and OmniChem, global leaders in large and small molecule contract manufacturing, announced that they are integrating as a unified CDMO and operating as Ajinomoto Bio-Pharma Services

Read more

Categories affiliated with Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services

Contact information

Address

Telephone

Website

View all contact information